Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of Concept.

Clin Pathol · 2019 · PMC6477754 · PMID 31041430

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

5 , 9 Of note, patients treated in first line with SSAs showed a trend for longer survival compared with those also receiving everolimus or treated with CT, in whom the relevant Ki-67 LI averaged 8.6%, 12.8%, and 28%, respectively.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.